Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mandy Wan

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
British Journal of Clinical Pharmacology|August 27, 2021
Population pharmacokinetics and dose optimisation of colecalciferol in paediatric patients with chronic kidney diseaseMandy Wan, Bruce Green, Arpana Aprameya Iyengar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 7, 2017
Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2-5 and on dialysisRukshana Shroff, Mandy Wan, Evi V Nagler, et al.
The British Journal of Dermatology|September 16, 2024
Methotrexate versus ciclosporin in the treatment of severe atopic eczema in children: an economic evaluationTracey H Sach, Kaitlyn R Chan, Ashley P Jones, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 7, 2017
Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease Stages 2-5 and on dialysisRukshana Shroff, Mandy Wan, Evi V Nagler, et al.
Rheumatology (Oxford, England)|July 29, 2024
Elicitation of expert prior opinion to design the BARJDM trial in juvenile dermatomyositisCharalampia Papadopoulou, Neil Martin, Nadia Rafiq, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 28, 2025
The role of nutritional vitamin D in chronic kidney disease-mineral and bone disorder in children and adults with chronic kidney disease, on dialysis, and after kidney transplantation-a European consensus statementHanne Skou Jørgensen, Marc Vervloet, Etienne Cavalier, et al.
Health Technology Assessment (Winchester, England)|November 5, 2021
Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCTSam Barratt, Julia A Bielicki, David Dunn, et al.
BMJ Open|May 25, 2019
Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)Mark D Lyttle, Julia A Bielicki, Sam Barratt, et al.
Trials|January 26, 2023
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocolDespina Eleftheriou, Yolanda Collaco Moraes, Cara Purvis, et al.
Health Technology Assessment (Winchester, England)|March 9, 2026
Prophylactic antibiotics to prevent chest infections in children with neurological impairment: the PARROT RCTPaul S McNamara, Ashley Paul Jones, Anne Chang, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
British Journal of Clinical Pharmacology|August 27, 2021
Population pharmacokinetics and dose optimisation of colecalciferol in paediatric patients with chronic kidney diseaseMandy Wan, Bruce Green, Arpana Aprameya Iyengar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 7, 2017
Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2-5 and on dialysisRukshana Shroff, Mandy Wan, Evi V Nagler, et al.
The British Journal of Dermatology|September 16, 2024
Methotrexate versus ciclosporin in the treatment of severe atopic eczema in children: an economic evaluationTracey H Sach, Kaitlyn R Chan, Ashley P Jones, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 7, 2017
Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease Stages 2-5 and on dialysisRukshana Shroff, Mandy Wan, Evi V Nagler, et al.
Rheumatology (Oxford, England)|July 29, 2024
Elicitation of expert prior opinion to design the BARJDM trial in juvenile dermatomyositisCharalampia Papadopoulou, Neil Martin, Nadia Rafiq, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 28, 2025
The role of nutritional vitamin D in chronic kidney disease-mineral and bone disorder in children and adults with chronic kidney disease, on dialysis, and after kidney transplantation-a European consensus statementHanne Skou Jørgensen, Marc Vervloet, Etienne Cavalier, et al.
Health Technology Assessment (Winchester, England)|November 5, 2021
Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCTSam Barratt, Julia A Bielicki, David Dunn, et al.
BMJ Open|May 25, 2019
Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)Mark D Lyttle, Julia A Bielicki, Sam Barratt, et al.
Trials|January 26, 2023
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocolDespina Eleftheriou, Yolanda Collaco Moraes, Cara Purvis, et al.
Health Technology Assessment (Winchester, England)|March 9, 2026
Prophylactic antibiotics to prevent chest infections in children with neurological impairment: the PARROT RCTPaul S McNamara, Ashley Paul Jones, Anne Chang, et al.
Pageof 5